Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2012 Mar;165(6):1609-1612.
doi: 10.1111/j.1476-5381.2011.01679.x.

Themed section: molecular pharmacology of GPCRs

Affiliations
Editorial

Themed section: molecular pharmacology of GPCRs

R J Summers. Br J Pharmacol. 2012 Mar.

Abstract

As our knowledge and understanding of the way in which GPCRs operate continues to grow rapidly, many new opportunities are emerging to develop novel therapeutic agents. This themed issue of the British Journal of Pharmacology contains a series of papers that cover recent developments and identify approaches that may help determine future directions. Many of these papers contain material that was presented at the 6th International Molecular Pharmacology of G Protein-Coupled Receptors meeting held at the Monash Institute of Pharmaceutical Sciences in Melbourne Australia in late 2010.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cavanaugh A, Huang Y, Breitwieser GE. Behind the curtain: cellular mechanisms for allosteric modulation of calcium sensing receptors. Br J Pharmacol. 2012;165:1670–1677. - PMC - PubMed
    1. Dang VC, Christie MJ. Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons. Br J Pharmacol. 2012;165:1704–1716. - PMC - PubMed
    1. Halls ML. Constitutive formation of an RXFP1-signalosome: a novel paradigm in GPCR function and regulation. Br J Pharmacol. 2012;165:1644–1658. - PMC - PubMed
    1. Insel PA, Snead A, Murray F, Zhang L, Yokouchi H, Katakia T, et al. GPCR expression in tissues and cells: are the optimal receptors being used as drug targets? Br J Pharmacol. 2012;165:1613–1616. - PMC - PubMed
    1. Kenakin TP. Biased signaling and allosteric machines; new vistas and challenges for drug discovery. Br J Pharmacol. 2012;165:1659–1669. - PMC - PubMed

Publication types